Charles River Laboratories International, Inc. CRL
Set alert
At close
Pre-market · Nov 3, 4:30 AM ET
- YTD
- +69.71%
- 1 year
- +88.00%
- Open
- 368.42
- Prev close
- 359.41
- Mkt cap
- 16.31B
- Vol
- 1.62M
- Avg vol
- 1.03M
- EPS
- -4.80
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 337.38
- High
- 369.61
- Forward P/E
- 26.55
- Beta
- 1.34
- Short ratio
- 2.77
- Inst. own
- 122.16%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 301.91
- 200-d avg
- 221.78
- 1y target
- 318.87
5D chart
Signals (154)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 3:30 PM | 13 hours ago |
| SMA: Bearish | Nov 2, 3:20 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 3:15 PM | 13 hours ago |
| SMA: Bearish | Nov 2, 3:10 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 3:05 PM | 13 hours ago |
| MACD: Buy Signal | Nov 2, 3:00 PM | 13 hours ago |
| RSI: Oversold | Nov 2, 2:45 PM | 13 hours ago |
| MACD: Sell Signal | Nov 2, 2:40 PM | 14 hours ago |
| SMA: Bearish | Nov 2, 2:35 PM | 14 hours ago |
| SMA: Bullish | Nov 2, 2:10 PM | 14 hours ago |
| MACD: Buy Signal | Nov 2, 2:10 PM | 14 hours ago |
| MACD: Sell Signal | Nov 2, 1:40 PM | 15 hours ago |
| SMA: Bearish | Nov 2, 1:25 PM | 15 hours ago |
| SMA: Bullish | Nov 2, 1:20 PM | 15 hours ago |
| SMA: Bearish | Nov 2, 12:40 PM | 16 hours ago |
| SMA: Bullish | Nov 2, 12:25 PM | 16 hours ago |
| SMA: Bearish | Nov 2, 12:20 PM | 16 hours ago |
| MACD: Buy Signal | Nov 2, 12:10 PM | 16 hours ago |
| SMA: Bullish | Nov 2, 12:05 PM | 16 hours ago |
| RSI: Oversold | Nov 2, 11:40 AM | 17 hours ago |
Newest 20 of 154.
News
15 hours ago zacks.com
Charles River's Q3 Earnings on Deck: What's in Store for the Stock?
CRL's Q3'26 results face pressure from declining segment revenues, but improving biopharma demand and strength in Microbial Solutions could provide support.
5 days ago zacks.com
Charles River Laboratories (CRL) Earnings Expected to Grow: Should You Buy?
Charles River (CRL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
6 days ago seekingalpha.com
Ariel Appreciation Fund Q3 2026 Scorecard: Buys, Sells, And Standouts
Charles River Laboratories advanced during the quarter following a strong earnings report and an increase to full-year guidance. We exited the NCLH position during the quarter and redeployed proceeds…
-
6 days ago benzinga.com
Charles River Laboratories' Virtual Control Group Database And Methodology To Be Used In An Upcoming Good Laboratory Practice-Compliant Study For Ipsen
This collaboration highlights Charles River’s and Ipsen’s dedication and commitment to championing the 3Rs (Replacement, Reduction, and Refinement of animal use in research) while upholding the…
6 days ago businesswire.com
Charles River Leverages Virtual Control Groups in GLP Studies
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River announces that its VCG database and methodology, designed to reduce animal use, will be used in an upcoming GLP study for Ipsen.
6 days ago defenseworld.net
Charles River Laboratories International (NYSE:CRL) Director James Foster Sells 24,042 Shares of Company Stock
Charles River Laboratories International, Inc. (NYSE: CRL - Get Free Report) Director James Foster sold 24,042 shares of the company's stock in a transaction dated Thursday, October 22nd. The shares…
-
1 week ago benzinga.com
Charles River Laboratories Announces Research Collaboration Agreement With FDA And Labcorp For Developing Sensitive Screening Tools To Quantify And Rank Abuse Potential Of New Drugs
Joint research effort seeks to improve abuse potential assessment tools to support drug development and public health decision-makingCharles River Laboratories International, Inc. (NYSE:CRL) today…
1 week ago benzinga.com
$1000 Invested In Charles River 15 Years Ago Would Be Worth This Much Today
Charles River (NYSE:CRL) has outperformed the market over the past 15 years by 4.33% on an annualized basis producing an average annual return of 17.1%. Currently, Charles River has a market…
1 week ago benzinga.com
SpaceX Jumps 10%, Nasdaq 100 Rises as AI Trade Returns: Stock Market Today
SpaceX's blowout third quarter and Super Micro's guidance hike revive the AI trade, lifting the Nasdaq 100 as Netflix and AT&T slide on results.
2 weeks ago benzinga.com
Here’s How Much You Would Have Made Owning Charles River Stock In The Last 20 Years
Charles River (NYSE:CRL) has outperformed the market over the past 20 years by 1.14% on an annualized basis producing an average annual return of 10.15%. Currently, Charles River has a market…
-
2 weeks ago benzinga.com
Morgan Stanley Maintains Overweight on Charles River, Raises Price Target to $340
Morgan Stanley analyst Ricky Goldwasser maintains Charles River (NYSE:CRL) with a Overweight and raises the price target from $300 to $340.
-
2 weeks ago benzinga.com
Charles River Laboratories International Partners With Magellan Stem Cells For Development, Clinical Advancement Of Stem Cell-Based Therapies, Regenerative Medicine Solutions
Charles River Laboratories International, Inc. (NYSE: CRL) and Magellan Stem Cells, a private Australian biotech and cell-therapy firm, announce their collaboration to support Magellan in the…
-
3 weeks ago benzinga.com
Charles River Laboratories and Autolomous Launch Apollo Orchestrate To Digitize Laboratory Execution Through autoloMATE Integration
Partnership reinforces continued investment in digitization, automation, and client-facing transparencyCharles River Laboratories International, Inc. (NYSE:CRL) and Autolomous today announced the…
-
ipowatch.in
Upcoming IPOs in India 2026 – Latest IPO Calendar
No matter how many years pass by, one thing that will never change is investors' strong interest in the Upcoming IPO. It seems like 2026 will be that year again, where investors are expecting the ...
-
finance.yahoo.com
Skydance Corporation (SKYD) Latest Stock News & Headlines - Yahoo Finance
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Skydance is entering a ...
-
finance.sina.com.cn
查尔斯河实验室收跌5.81%，成交额5.53亿美元
该公司提供基本产品和服务，帮助全球的制药和生物技术公司、政府机构和学术机构加速该公司的研究和药物开发工作。该公司的研究模型与服务分部包括提供基础工具的业务，这些工具使该公司的客户能够发现新分子：研究模型和研究模型服务。该公司的发现与安全性评估（DSA）分部提供受监管和非受监管的DSA服务，以支持潜在新药的研究、开发和法规要求的安全性测试，包括体外、体内和计算机模拟研究、实验室支持服务以及战略性非临…
finance.yahoo.com
Charles River's Q3 Earnings on Deck: What's in Store for the Stock?
CRL's Q3'26 results face pressure from declining segment revenues, but improving biopharma demand and strength in Microbial ...
msn.com
Kiplinger's earnings calendar and analysis for this week
Check out our earnings calendar for this week, as well as our previews and recaps of the more noteworthy reports.
-
markets.financialcontent.com
What to expect from Charles River Laboratories’s (CRL) Q3 earnings
Charles River Laboratories beat analysts’ revenue expectations last quarter, reporting revenues of $1.00 billion, down 2.7% year on year. It was a very strong quarter for the company, with a solid ...
-
baynews9.com
Discover Crystal River releases 2025 Visitor Impact report showing tourist impact on the area
CRYSTAL RIVER, Fla. — Citrus County’s yearly visitor economic impact report for 2025 is in and it’s showing some pretty big numbers. According to Discover Crystal River's report, more than $428 ...
-
marketwatch.com
Charles River Laboratories International Inc. stock underperforms Monday when compared to competitors
This was the stock's second consecutive day of losses.
-
morningstar.com
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Unicycive Therapeutics (NASDAQ: UNCY) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Unicycive Therapeutics (NASDAQ: UNCY) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026 Faruqi & Faruqi, LLP ...